Concurrent Composite Lymphomas Collectively Bearing Three Diagnostic Entities of Shared Clonal Origin

Hemasphere. 2022 Mar 29;6(4):e705. doi: 10.1097/HS9.0000000000000705. eCollection 2022 Apr.

Waleed Alduaij^{1

2}, Laura K Hilton¹, Muntadhar Al Moosawi³, Susana Ben-Neriah¹, Barbara Meissner¹, Merrill Boyle¹, Kelly Mekwunye¹, David W Scott^{1

4}, Heather A Leitch^{5

6}, Jeffrey W Craig^{3

7}

¹ Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.
² Clinician Investigator Program, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
³ Hematological Pathology, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
⁴ Division of Medical Oncology, University of British Columbia, Vancouver, British Columbia, Canada.
⁵ Hematology, St. Paul's Hospital, Vancouver, British Columbia, Canada.
⁶ Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
⁷ Department of Pathology and Laboratory Medicine, British Columbia Cancer, Vancouver, British Columbia, Canada.

No abstract available